Home > Healthcare > Medical Services > Lab Services > U.S. Office-based Labs Market

U.S. Office-based Labs Market Trends

Report ID: GMI8427
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

U.S. Office-based Labs Market Trends

The increasing approval of endovascular procedures in office-based labs indicates a shift towards more accessible, cost-effective, and patient-centred vascular care, providing minimally invasive treatments with enhanced convenience and outcomes.

Endovascular procedures performed in OBLs enhance access to patient care, especially in rural or underserved areas. This allows patients to receive treatment closer to home, reducing the necessity for long-distance travel to large medical centers.
Endovascular treatment devices play a pivotal role in office-based labs by providing minimally invasive solutions for a broad spectrum of vascular conditions. These devices encompass various technologies, including catheters, balloons, stents, atherectomy devices, and embolic protection devices.
Moreover, the growing approval of endovascular procedures in office-based labs offers numerous benefits, such as increased accessibility, convenience, cost-effectiveness, minimally invasive approaches, improved patient experience, workflow optimization, specialized expertise, flexibility, and infection control.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. office-based labs industry was USD 11.2 billion in revenue in 2023 and is estimated to expand at 7.6% CAGR during 2024-2032 driven by the growing demand by medical service providers due to the increasing prevalence of target diseases.

The peripheral vascular intervention segment is estimated to reach USD 6.3 billion in revenue by 2032 owing to its increasing adoption for managing the treatment of peripheral arterial disease (PAD) across the region.

The single specialty labs segment generated USD 4.7 billion in 2023 and is set to gain significant traction through 2032 as these labs offer cost-efficient solutions, patient-centric approaches, innovation opportunities, and enhanced referral networks.

Some of the leading U.S. office-based labs industry players are Koninklijke Philips N.V, GE Healthcare, Siemens Healthineers AG, Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Cardiovascular Systems, Inc., Envision Healthcare, Surgery Care Associates, Inc., Surgery Partners, National Cardiovascular Partners, and TH Medical.